Organic growth reached 15% year-over-year, driven by strong direct market performance and new product launches. EBIT margin remained at 27%, with double-digit growth in both pediatric and adult segments. Currency effects weighed on reported growth and gross margin.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.